266 related articles for article (PubMed ID: 28329705)
41. STING, a promising target for small molecular immune modulator: A review.
Liu Y; Lu X; Qin N; Qiao Y; Xing S; Liu W; Feng F; Liu Z; Sun H
Eur J Med Chem; 2021 Feb; 211():113113. PubMed ID: 33360799
[TBL] [Abstract][Full Text] [Related]
42. Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-κB signaling.
Slowicka K; Vereecke L; Mc Guire C; Sze M; Maelfait J; Kolpe A; Saelens X; Beyaert R; van Loo G
Eur J Immunol; 2016 Apr; 46(4):971-80. PubMed ID: 26677802
[TBL] [Abstract][Full Text] [Related]
43. Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells.
Jijon HB; Madsen KL; Walker JW; Allard B; Jobin C
Eur J Immunol; 2005 Mar; 35(3):718-26. PubMed ID: 15724247
[TBL] [Abstract][Full Text] [Related]
44. Highly Efficient Preparation of Cyclic Dinucleotides
Lv Y; Sun Q; Wang X; Lu Y; Li Y; Yuan H; Zhu J; Zhu D
Front Microbiol; 2019; 10():2111. PubMed ID: 31572324
[TBL] [Abstract][Full Text] [Related]
45. Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation.
Bitzer A; Basler M; Krappmann D; Groettrup M
Mol Immunol; 2017 Mar; 83():147-153. PubMed ID: 28157553
[TBL] [Abstract][Full Text] [Related]
46. Cytosolic sensor STING in mucosal immunity: a master regulator of gut inflammation and carcinogenesis.
Hu Q; Zhou Q; Xia X; Shao L; Wang M; Lu X; Liu S; Guan W
J Exp Clin Cancer Res; 2021 Jan; 40(1):39. PubMed ID: 33485379
[TBL] [Abstract][Full Text] [Related]
47. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.
Ukil A; Maity S; Das PK
Br J Pharmacol; 2006 Sep; 149(1):121-31. PubMed ID: 16880762
[TBL] [Abstract][Full Text] [Related]
48. Lipopolysaccharide stimulates Epac1-mediated Rap1/NF-kappaB pathway in Raw 264.7 murine macrophages.
Moon EY; Pyo S
Immunol Lett; 2007 Jun; 110(2):121-5. PubMed ID: 17532477
[TBL] [Abstract][Full Text] [Related]
49. STING and liver disease.
Chen C; Yang RX; Xu HG
J Gastroenterol; 2021 Aug; 56(8):704-712. PubMed ID: 34159442
[TBL] [Abstract][Full Text] [Related]
50. Cyclic dinucleotides at the forefront of innate immunity.
Zaver SA; Woodward JJ
Curr Opin Cell Biol; 2020 Apr; 63():49-56. PubMed ID: 31958669
[TBL] [Abstract][Full Text] [Related]
51. Recognition of cyclic dinucleotides and folates by human SLC19A1.
Zhang Q; Zhang X; Zhu Y; Sun P; Zhang L; Ma J; Zhang Y; Zeng L; Nie X; Gao Y; Li Z; Liu S; Lou J; Gao A; Zhang L; Gao P
Nature; 2022 Dec; 612(7938):170-176. PubMed ID: 36265513
[TBL] [Abstract][Full Text] [Related]
52. STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity.
Dane EL; Belessiotis-Richards A; Backlund C; Wang J; Hidaka K; Milling LE; Bhagchandani S; Melo MB; Wu S; Li N; Donahue N; Ni K; Ma L; Okaniwa M; Stevens MM; Alexander-Katz A; Irvine DJ
Nat Mater; 2022 Jun; 21(6):710-720. PubMed ID: 35606429
[TBL] [Abstract][Full Text] [Related]
53. Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein.
Smola M; Gutten O; Dejmek M; Kožíšek M; Evangelidis T; Tehrani ZA; Novotná B; Nencka R; Birkuš G; Rulíšek L; Boura E
Angew Chem Int Ed Engl; 2021 Apr; 60(18):10172-10178. PubMed ID: 33616279
[TBL] [Abstract][Full Text] [Related]
54. Orally acquired cyclic dinucleotides drive dSTING-dependent antiviral immunity in enterocytes.
Segrist E; Dittmar M; Gold B; Cherry S
Cell Rep; 2021 Dec; 37(13):110150. PubMed ID: 34965418
[TBL] [Abstract][Full Text] [Related]
55. Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides.
Cao X; Xiao Y; Huiting E; Cao X; Li D; Ren J; Fedorova I; Wang H; Guan L; Wang Y; Li L; Bondy-Denomy J; Feng Y
Mol Cell; 2024 Jan; 84(2):375-385.e7. PubMed ID: 38103556
[TBL] [Abstract][Full Text] [Related]
56. The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development.
Yan H; Chen W
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452042
[TBL] [Abstract][Full Text] [Related]
57. Biotechnological production of cyclic dinucleotides-Challenges and opportunities.
Bartsch T; Becker M; Rolf J; Rosenthal K; Lütz S
Biotechnol Bioeng; 2022 Mar; 119(3):677-684. PubMed ID: 34953086
[TBL] [Abstract][Full Text] [Related]
58. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance.
Jang SC; Economides KD; Moniz RJ; Sia CL; Lewis N; McCoy C; Zi T; Zhang K; Harrison RA; Lim J; Dey J; Grenley M; Kirwin K; Ross NL; Bourdeau R; Villiger-Oberbek A; Estes S; Xu K; Sanchez-Salazar J; Dooley K; Dahlberg WK; Williams DE; Sathyanarayanan S
Commun Biol; 2021 Apr; 4(1):497. PubMed ID: 33888863
[TBL] [Abstract][Full Text] [Related]
59. Enzymatic Syntheses and Applications of Fluorescent Cyclic Dinucleotides.
Li Y; Ludford PT; Fin A; Rovira AR; Tor Y
Chemistry; 2020 May; 26(27):6076-6084. PubMed ID: 32157755
[TBL] [Abstract][Full Text] [Related]
60. Enzymatic Synthesis of 3'-5', 3'-5' Cyclic Dinucleotides, Their Binding Properties to the Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations.
Novotná B; Holá L; Staś M; Gutten O; Smola M; Zavřel M; Vavřina Z; Buděšínský M; Liboska R; Chevrier F; Dobiaš J; Boura E; Rulíšek L; Birkuš G
Biochemistry; 2021 Dec; 60(48):3714-3727. PubMed ID: 34788017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
